| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Comparative Analysis of the Value of HER2 Immunohistochemistry Scoring in Primary and Metastatic Breast Cancer, in the Era of HER2 “Low” Breast Cancers
|
Bhardwaj, Swati
|
|
|
25 |
4 |
p. 354-357
|
article
|
| 2 |
A Radiomic and Clinical Data‐Based Risk Model for Malignancy Prediction of Breast BI‐RADS 4A Microcalcifications
|
Brunetti, Nicole
|
|
|
25 |
4 |
p. e461-e469
|
article
|
| 3 |
Comparison of Systemic Inflammatory Indices With the Oncotype DX Recurrence Score and the Nottingam Prognostic Index in Early Hormone Receptor Positive Ductal Breast Cancer
|
Huws, Anita M.
|
|
|
25 |
4 |
p. 358-367
|
article
|
| 4 |
Development and Evaluation of a Remote Monitoring Regional Adjuvant Abemaciclib Service for Patients With High-Risk Early Breast Cancer
|
Brown, Nicole L.
|
|
|
25 |
4 |
p. 368-379.e8
|
article
|
| 5 |
Editorial Board
|
|
|
|
25 |
4 |
p. A5
|
article
|
| 6 |
Effectiveness of Adjuvant Capecitabine in Triple-Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Treatment: A Real-World Evidence Study in Korea
|
Kim, Min Jeong
|
|
|
25 |
4 |
p. e431-e439.e4
|
article
|
| 7 |
Factors Associated With Short- and Long-Term Survival in Metastatic HER2-Positive Breast Cancer
|
Leone, José P.
|
|
|
25 |
4 |
p. 344-353
|
article
|
| 8 |
High Risk of Metabolic Dysfunction in Nonobese Breast Cancer Survivors
|
da Silva-Filho, Pedro Paulo P.
|
|
|
25 |
4 |
p. e479-e486
|
article
|
| 9 |
Identification and Management of Medical Comorbidities in Patients With HR+/HER2– Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: Literature Review and Recommendations From Experts in Spain Opinion
|
Hinojo, Carmen
|
|
|
25 |
4 |
p. e403-e418.e2
|
article
|
| 10 |
Influence of Postmastectomy Radiotherapy on Overall Survival in Patients With Clinical Prognostic Stage I-III Breast Cancer With Positive Responses and Achieving YPN0 Following Neoadjuvant Therapy: A Propensity Score Matching Based on the SEER Database
|
Zhang, YuFeng
|
|
|
25 |
4 |
p. e368-e382
|
article
|
| 11 |
Investigation of HOTAIR rs12826786, rs920778 and rs4759314 Variants With Breast Cancer Susceptibility and Clinicopathological Characteristics in a Mexican Population
|
Rosales-Reynoso, Mónica Alejandra
|
|
|
25 |
4 |
p. 325-334
|
article
|
| 12 |
Is Immediate Breast Reconstruction an Option for Elderly Women? A Comparative Study Between Elderly and Younger Population
|
Marcadet, Julie
|
|
|
25 |
4 |
p. e440-e449
|
article
|
| 13 |
Is Progesterone Receptor a Neglected Feature in Breast Cancer? A Retrospective Study Analysing the Clinicopathological Characteristics of Breast Cancer Based on Progesterone Receptor Status
|
Rodrigues, Ilda
|
|
|
25 |
4 |
p. e331-e340
|
article
|
| 14 |
Menopausal Symptom Burden in Premenopausal Breast Cancer Patients: Interaction of Chemotherapy and Ovarian Function Suppression on Tamoxifen Treatment
|
Lee, Young-Won
|
|
|
25 |
4 |
p. 335-343
|
article
|
| 15 |
Mutations in Necroptosis-Related Genes Reported in Breast Cancer: A Cosmic and Uniport Database-Based Study
|
Thakur, Banita
|
|
|
25 |
4 |
p. e341-e359
|
article
|
| 16 |
Optimizing Postneoadjuvant Treatment of Residual Breast Cancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy: A Combined Analysis of DFCI 05-055 and DFCI 09-134/TBCRC 012/ABCDE Clinical Trials
|
Trapani, Dario
|
|
|
25 |
4 |
p. e419-e430.e5
|
article
|
| 17 |
Oral Anticancer Therapies: Addressing Nonadherence in Patients With Breast Cancer
|
Cazzaniga, M.E.
|
|
|
25 |
4 |
p. 307-324
|
article
|
| 18 |
Predicting Late Recurrence in Male Estrogen Receptor-Positive Breast Cancer With Clinical Treatment Score Post-5 years: A SEER database analysis of 65,711 cases
|
Wang, Fenhua
|
|
|
25 |
4 |
p. e360-e367.e1
|
article
|
| 19 |
Pyrotinib Plus Taxanes or Vinorelbine for the Treatment of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Prospective Evaluation of Efficacy and Safety
|
Xiong, Weili
|
|
|
25 |
4 |
p. 380-387
|
article
|
| 20 |
Response to “The Impact of Baseline Comorbidities and Performance Status on HER2-Targeted Therapy Outcomes”
|
Kook, Yoonwon
|
|
|
25 |
4 |
p. 390
|
article
|
| 21 |
Study on the Differentiation of Infiltrating Breast Cancer Molecular Subtypes Based on Ultrasound Radiomics
|
Liu, Hanqin
|
|
|
25 |
4 |
p. e450-e460
|
article
|
| 22 |
Table of Contents
|
|
|
|
25 |
4 |
p. A7-A11
|
article
|
| 23 |
The Added Value of Physical Examination for Breast Cancer Recurrence Detection in Women: A Systematic Review
|
Godding, L.T.H.
|
|
|
25 |
4 |
p. e383-e393.e2
|
article
|
| 24 |
The Difference of RCB 0 and RCB I in Prognosis of Breast Cancer After Neoadjuvant Therapy: A Meta-Analysis
|
Tao, Xinlong
|
|
|
25 |
4 |
p. 299-306.e1
|
article
|
| 25 |
The Effect of CALM Intervention on Negative Emotions and Sleep Quality in Patients Undergoing Endocrine Therapy for Breast Cancer
|
Jia, Yingxue
|
|
|
25 |
4 |
p. e470-e478
|
article
|
| 26 |
The Impact of Baseline Comorbidities and Performance Status on HER2-Targeted Therapy Outcomes
|
Akbari, Amir Reza
|
|
|
25 |
4 |
p. 388-389
|
article
|
| 27 |
Trends in Incidence of Invasive Lobular Carcinoma of the Breast by Race: Patterns by Age, Cancer Stage, and Socioeconomic Factors in the United States, 1992-2019
|
Quinn, Ryann M.
|
|
|
25 |
4 |
p. e394-e402.e8
|
article
|
Journal description